← FDA DRUG APPROVALS

FDA ANDA · ANDA085620

ESTRADIOL CYPIONATE

Sponsor: DR REDDYS

APPLICATION
ANDA085620
TYPE
ANDA
ORIGINAL APPROVAL
1981-11-02
LATEST ACTION
2024-02-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

ESTRADIOL CYPIONATEDiscontinued
ESTRADIOL CYPIONATE 5MG/ML · INJECTABLE · INJECTION

Approval history

2024-02-16Labeling · Supplement 20 · standardAP
1999-02-19Manufacturing (CMC) · Supplement 18AP
1999-02-02Manufacturing (CMC) · Supplement 17AP
1998-03-17Manufacturing (CMC) · Supplement 16AP
1996-12-04Manufacturing (CMC) · Supplement 15AP
1996-08-20Labeling · Supplement 14AP
1991-07-01Labeling · Supplement 13AP
1990-12-12Labeling · Supplement 21AP
1990-12-12Labeling · Supplement 12AP
1988-10-05Manufacturing (CMC) · Supplement 11AP
1988-10-05Manufacturing (CMC) · Supplement 10AP
1988-10-05Manufacturing (CMC) · Supplement 9AP
1986-05-01Manufacturing (CMC) · Supplement 3AP
1983-12-22Manufacturing (CMC) · Supplement 1AP
1981-11-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →